Curto-García Natalia, García-Suárez Julio, Callejas Chavarria Marta, Gil Fernández Juan José, Martín Guerrero Yolanda, Magro Mazo Elena, Marcellini Antonio Shelly, Juárez Luis Miguel, Gutierrez Isabel, Arranz Juan José, Montalvo Irene, Elvira Carmen, Domínguez Pilar, Díaz María Teresa, Burgaleta Carmen
Department of Haematology, University Hospital Príncipe de Asturias, Carretera Alcalá- Meco s/n, Alcalá de Henares, Madrid, Spain.
Nursing Staff of the Haematology Unit, University Hospital Príncipe de Asturias, Carretera Alcalá- Meco s/n, Alcalá de Henares, Madrid, Spain.
Support Care Cancer. 2016 Jan;24(1):93-101. doi: 10.1007/s00520-015-2754-1. Epub 2015 May 3.
Use of peripherally inserted central catheters (PICCs) has markedly increased during the last decade. However, there are few studies on use of PICCs in patients with haematological malignancies (HM) receiving intensive chemotherapy. Preliminary data suggest a higher rate of PICC-related complications in these high-risk patients. This prospective observational single-centre study aimed to investigate PICC-related complications after implementation of a multidisciplinary approach to PICC care and compared it with previous literature.
A total of 44 PICCs were inserted in 36 patients (27.3%, thrombocytopenia <50 × 10(9)/L at insertion) over 5045 PICC days (median duration, 114.5 days).
No major insertion-related complications were observed. Major late complications were obstruction in 13.6% (1.19/1000 PICC days) of patients, catheter-related bloodstream infection in 6.8% (0.59/1000 PICC days), and catheter-related thrombosis in 4.5% (0.39/1000 PICC days). Premature PICC removal occurred in 34% (2.97/1000 PICC days) of patients. The overall rate of potentially major dangerous complications was particularly low (11.36%, 0.99/1000 PICC days) compared with previous studies.
This study highlights the utility of a multidisciplinary approach for PICC care in adults with HM receiving intensive chemotherapy. We provide further data to support use of PICCs in such patient populations.
在过去十年中,经外周静脉穿刺中心静脉置管(PICC)的使用显著增加。然而,关于血液系统恶性肿瘤(HM)患者在接受强化化疗时使用PICC的研究较少。初步数据表明,这些高危患者中PICC相关并发症的发生率较高。这项前瞻性观察性单中心研究旨在调查在实施多学科PICC护理方法后PICC相关并发症,并与先前的文献进行比较。
在5045个PICC日(中位持续时间为114.5天)期间,共为36例患者插入了44根PICC(27.3%,置管时血小板减少<50×10⁹/L)。
未观察到与置管相关的重大并发症。主要晚期并发症包括13.6%(1.19/1000 PICC日)的患者发生堵塞,6.8%(0.59/1000 PICC日)的患者发生导管相关血流感染,4.5%(0.39/1000 PICC日)的患者发生导管相关血栓形成。34%(2.97/1000 PICC日)的患者提前拔除了PICC。与先前的研究相比,潜在重大危险并发症的总体发生率特别低(11.36%,0.99/1000 PICC日)。
本研究强调了多学科方法在接受强化化疗的HM成年患者PICC护理中的实用性。我们提供了进一步的数据来支持在此类患者群体中使用PICC。